HOME >> BIOLOGY >> NEWS
Prevalence of overactive bladder is overestimated

According to the International Continence Society, overactive bladder is a symptom-defined condition characterized by urinary urgency, with or without urgency incontinence, usually with urinary frequency and nocturia (night-time urination). The term overactive bladder is appropriate if there is no proven urinary tract infection or other obvious pathology.

Overactive bladder was identified in 6.5% of Finnish men and 9.3% of women. In younger age groups the condition was more common among women, but among those over 60 years old it was more common among men. Urinary frequency and nocturia were generally more common than usual among those with an overactive bladder. However, most reported urinary frequency and nocturia was not overactive bladder.

The research is based on a questionnaire conducted 2003-2004 among 3,000 Finnish women and 3,000 Finnish men. Their ages ranged from 18 to 79. The subjects were taken from the population register.

Professor Teuvo Tammela and Professor Anssi Auvinen are in charge of the research group, whose members are from the University of Tampere, Tampere University Hospital, Helsinki University Central Hospital and the South Karelian Central Hospital in Lappeenranta.


'"/>

Contact: Dr. Kari Tikkinen
kari.tikkinen@fimnet.fi
358-331-164-120
Public Library of Science
6-Feb-2007


Page: 1

Related biology news :

1. Prevalence of infection in a population can shape parasite virulence
2. MIT: Pulsing light silences overactive neurons
3. Scientists move closer to bio-engineered bladders
4. UF scientists work to develop simple bladder cancer test
5. Lung and bladder cancer deaths continue decades after arsenic exposure
6. Proteins effects essential for kidney-to-bladder urine transfer
7. Broccoli packs powerful punch to bladder cancer cells
8. Blocking PLK-1 to beat bladder cancer
9. New risks for bladder cancer identified by MIT team

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 25, 2020 , ... ... targeting mitochondria, in partnership with Essex Bio-Technology, a bio-pharmaceutical company specializing in ... 3 VISTA-2 study of SkQ1 ophthalmic solution in patients with moderate to ...
(Date:8/21/2020)... (PRWEB) , ... August 18, 2020 , ... ... to cell therapy, today announced that the U.S. Food and Drug Administration (FDA) ... Sentien’s lead asset, SBI-101, for the treatment of severe COVID-19. Approval of this ...
(Date:8/12/2020)... Mich. (PRWEB) , ... August 11, 2020 , ... ... R&D subsidiary based in Princeton, NJ, have entered into license agreements with Housey ... and development. Both Roche and J&J have annual Research and Development spending ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... Mass. and SOMERSET, N.J (PRWEB) , ... July ... ... leading genome editing company, and Catalent, the leading global provider of advanced delivery ... consumer health products, today announced that they have entered into a strategic partnership ...
(Date:7/18/2020)... ... 16, 2020 , ... After research model surgery and catheter implantation, the long ... only the beginning of a successful study, while protecting and accessing the catheter or ... Head of Surgery from Envigo in a live webinar on ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license to ... move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. ...
(Date:7/1/2020)... ... 2020 , ... MedShift , a leading medical technology ... obstacles created as a result of COVID-19. As a provider at the forefront ... and medical manufacturers by expanding access to device offerings, technology services, and marketing ...
Breaking Biology Technology:
Cached News: